2015
DOI: 10.1016/j.nano.2014.12.013
|View full text |Cite
|
Sign up to set email alerts
|

Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines

Abstract: Nanoparticulate delivery systems represent an area of particular promise for nanoneuromedicines. They possess significant potential for desperately needed therapies designed to combat a range of disorders associated with aging. As such, the field was selected as the focus for the 2014 meeting of the American Society for Nanomedicine. Regenerative, protective, immune modulatory, anti-microbial and anti-inflammatory products, or imaging agents are readily encapsulated in or conjugated to nanoparticles and as suc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
42
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 48 publications
(42 citation statements)
references
References 185 publications
0
42
0
Order By: Relevance
“…Thus, conceiving innovative strategies to optimize the treatment of disease with drugs available on the market is of great value, especially when a direct translation into the clinical phase is envisioned. In this sense, the extensive development that has had clinical pharmacology, dealing with the effectiveness and safety of drugs in humans [44] has enabled the improvement of pharmacotherapy against HIV in children and pregnant women using the TDM as a fundamental tool [45][46][47][48][49]. However, it is known that drug levels in plasma often not reliably correlate with the accumulation thereof in tissues separated by barriers such as the BBB.…”
Section: Future Perspectivementioning
confidence: 99%
See 1 more Smart Citation
“…Thus, conceiving innovative strategies to optimize the treatment of disease with drugs available on the market is of great value, especially when a direct translation into the clinical phase is envisioned. In this sense, the extensive development that has had clinical pharmacology, dealing with the effectiveness and safety of drugs in humans [44] has enabled the improvement of pharmacotherapy against HIV in children and pregnant women using the TDM as a fundamental tool [45][46][47][48][49]. However, it is known that drug levels in plasma often not reliably correlate with the accumulation thereof in tissues separated by barriers such as the BBB.…”
Section: Future Perspectivementioning
confidence: 99%
“…It is for this reason that in the last decade a large number of investigations that focus on nanotechnology have been developed. Regenerative, protective, immune modulatory, antimicrobial and anti-inflammatory products or imaging agents are readily encapsulated in or conjugated to nanoparticles and as such facilitate the delivery of drug payloads to specific action sites across the BBB [49] in order to optimize pharmacotherapy.…”
Section: Future Perspectivementioning
confidence: 99%
“…Extensive studies have been published regarding the impact of nanotechnology in a broad spectrum of stem cell types, including pluripotent [47], neural [48,49], and hematopoietic [50] cells-driven tissue engineering.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…Micro/nanoparticle formulations have been successfully developed for delivering therapeutic molecules, such as drugs, antibiotics, growth factors, and cytokines [22]. Both natural and synthetic polymers can be used for nanoparticle fabrication and encapsulating bioactive molecules.…”
Section: Introductionmentioning
confidence: 99%